Real-time enrollment status for this her2+ solid tumors clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 11:12 AM UTC
| NCT Number | NCT06126276 |
| Recruiting Status | Recruiting |
| Condition | HER2+ Solid Tumors |
| Phase | PHASE2 |
| Target Enrollment | 70 participants |
| Active Locations | 187 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | July 13, 2026 (5 days ago) |
As of July 18, 2026: Clinical trial NCT06126276 is currently recruiting participants. This phase2 study for her2+ solid tumors is actively seeking new participants at 187 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06126276 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 187 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06126276 was last updated 5 days ago (July 13, 2026). HelloStudys verifies this status automatically.